Profile of blonanserin for the treatment of schizophrenia

Blonanserin was developed as an antipsychotic drug in Japan and approved for the treatment of schizophrenia. It belongs to a series of 4-phenyl-2-(1-piperazinyl)pyridines and acts as an antagonist at dopamine D(2), D(3), and serotonin 5-HT(2A) receptors. Blonanserin has low affinity for 5-HT(2C), ad...

Descripción completa

Detalles Bibliográficos
Autores principales: Tenjin, Tomomi, Miyamoto, Seiya, Ninomiya, Yuriko, Kitajima, Rei, Ogino, Shin, Miyake, Nobumi, Yamaguchi, Noboru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3677929/
https://www.ncbi.nlm.nih.gov/pubmed/23766647
http://dx.doi.org/10.2147/NDT.S34433

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3677929/
https://www.ncbi.nlm.nih.gov/pubmed/23766647
http://dx.doi.org/10.2147/NDT.S34433

Ejemplares similares